Order Article Reprints

Shah VM, Rizvi S, Smith A, Tsuda M, Krieger M, Pelz C, MacPherson K, Eng J, Chin K, Munks MW, et al. Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment. Pharmaceutics. 2023; 15(12):2651. https://doi.org/10.3390/pharmaceutics15122651

Shah, Vidhi M., Syed Rizvi, Alexander Smith, Motoyuki Tsuda, Madeline Krieger, Carl Pelz, Kevin MacPherson, Jenny Eng, Koei Chin, Michael W. Munks, and et al. 2023. "Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment" Pharmaceutics 15, no. 12: 2651. https://doi.org/10.3390/pharmaceutics15122651

Shah, V. M., Rizvi, S., Smith, A., Tsuda, M., Krieger, M., Pelz, C., MacPherson, K., Eng, J., Chin, K., Munks, M. W., Daniel, C. J., Al-Fatease, A., Yardimci, G. G., Langer, E. M., Brody, J. R., Sheppard, B. C., Alani, A. W., & Sears, R. C. (2023). Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment. Pharmaceutics, 15(12), 2651. https://doi.org/10.3390/pharmaceutics15122651